Skip to main content

Table 1 Baseline characteristics of pregnant women assessed for stillbirth

From: Pregnancy outcomes and risk of placental malaria after artemisinin-based and quinine-based treatment for uncomplicated falciparum malaria in pregnancy: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis

CharacteristicAllALASAQASMQDPAAPASASSPQQC
N% (N)
Mean (SD)
N% (N)
Mean (SD)
N% (N)
Mean (SD)
N% (N)
Mean (SD)
N% (N)
Mean (SD)
N% (N)
Mean (SD)
N% (N)
Mean (SD)
N% (N)
Mean (SD)
N% (N)
Mean (SD)
N% (N)
Mean (SD)
EGA (week)433424.6 (5.7)108724.3 (5.7)77524.1 (5.1)96525.3 (5.3)83724.4 (5.7)8126.2 (7.1)19326.6 (7.4)15424.4 (5.8)18423.8 (6.3)5826.8 (6.5)
Age group <20433432.0 (1388)108736.5 (397)77531.7 (246)96528.1 (271)83739.8 (333)8128.4 (23)19319.2 (37)15420.1 (31)18420.7 (38)5820.7 (12)
 20–24 32.3 (1399) 31.1 (338) 31.6 (245) 33.6 (324) 30.0 (251) 27.2 (22) 24.9 (48) 55.2 (85) 39.7 (73) 22.4 (13)
 25–29 19.3 (836) 17.8 (194) 20.1 (156) 21.2 (205) 16.6 (139) 22.2 (18) 21.2 (41) 17.5 (27) 20.1 (37) 32.8 (19)
 30–34 9.7 (419) 8.1 (88) 10.7 (83) 10.6 (102) 8.4 (70) 13.6 (11) 14.5 (28) 3.9 (6) 13.0 (24) 12.1 (7)
 >35 (years) 6.7 (292) 6.4 (70) 5.8 (45) 6.5 (63) 5.3 (44) 8.6 (7) 20.2 (39) 3.2 (5) 6.5 (12) 12.1 (7)
Gravidity 1429735.4 (1519)105335.1 (370)77436.4 (282)96533.2 (320)83738.4 (321)8129.6 (24)19327.5 (53)15448.7 (75)18232.4 (59)5825.9 (15)
 2 23.4 (1005) 23.2 (244) 22.5 (174) 24.1 (233) 24.9 (208) 21.0 (17) 15.0 (29) 24.7 (38) 25.8 (47) 25.9 (15)
 ≥3 41.3 (1773) 41.7 (439) 41.1 (318) 42.7 (412) 36.8 (308) 49.4 (40) 57.5 (111) 26.6 (41) 41.8 (76) 48.3 (28)
Parity 0432942.7 (1847)108342.6 (461)77441.1 (318)96542.6 (411)83747.6 (398)8133.3 (27)19330.1 (58)15456.5 (87)18437.0 (68)5832.8 (19)
 1 21.8 (945) 20.9 (226) 22.4 (173) 20.9 (202) 22.6 (189) 24.7 (20) 19.7 (38) 23.4 (36) 25.0 (46) 25.9 (15)
 ≥2 35.5 (1537) 36.6 (396) 36.6 (283) 36.5 (352) 29.9 (250) 42.0 (34) 50.3 (97) 20.1 (31) 38.0 (70) 41.4 (24)
Height (cm)3809155.8 (6.9)934156.1 (6.6)775157.9 (6.5)927156.1 (7.3)837155.3 (6.3)33150.2 (8.3)136151.7 (5.6)118150.0 (7.0)49153.3 (5.1)0 
Weight (kg)433353.9 (8.3)108653.7 (7.4)77556.3 (8.8)96554.0 (8.5)83754.4 (8.2)8149.8 (6.6)19349.5 (6.4)15447.8 (6.9)18455.2 (9.4)5849.8 (5.5)
BMI <18.538096.3 (239)9345.8 (54)7754.9 (38)9276.8 (63)8375.5 (46)336.1 (2)1368.1 (11)11818.6 (22)496.1 (3)0 
 18.5–24.9 79.9 (3044) 84.7 (791) 78.8 (611) 77.9 (722) 77.8 (651) 78.8 (26) 83.8 (114) 72.0 (85) 89.8 (44)  
 25.0–29.9 12.0 (458) 8.9 (83) 12.4 (96) 13.4 (124) 15.4 (129) 9.1 (3) 7.4 (10) 9.3 (11) 4.1 (2)  
 ≥30 (kg/m2) 1.8 (68) 0.6 (6) 3.9 (30) 1.9 (18) 1.3 (11) 6.1 (2) 0.7 (1) 0.0 (0) 0.0 (0)  
Fever (temperature >37.5°C)42929.2 (395)10868.2 (89)7754.8 (37)9649.8 (94)8344.2 (35)8124.7 (20)19325.4 (49)11724.8 (29)18416.8 (31)5819.0 (11)
Haemoglobin on day 0 (g/dL)430810.0 (1.4)107510.2 (1.4)77510.0 (1.3)9639.9 (1.4)83410.0 (1.4)809.4 (1.5)1939.5 (1.5)1529.3 (1.4)17910.2 (1.8)579.1 (1.6)
Parasitaemia (log10/μL)43343.0 (0.9)10873.1 (0.8)7752.8 (0.8)9653.0 (0.8)8372.9 (0.8)813.6 (1.1)1933.3 (1.0)1543.4 (0.8)1843.4 (0.9)583.3 (1.1)
Presence of gametocytes42713.8 (161)10833.9 (42)7753.0 (23)9461.7 (16)8373.8 (32)813.7 (3)18910.1 (19)1183.4 (4)1849.2 (17)588.6 (5)
Mixed infection43340.7 (32)10870.9 (10)7750.0 (0)9650.0 (0)8370.7 (6)811.2 (1)1936.2 (12)1540.0 (0)1840.0 (0)585.2 (3)
HIV infection27301.3 (35)8081.4 (11)5730.5 (3)5700.2 (1)6680.9 (6)0 0 2722.2 (6)849.5 (8)0 
  1. AAP artesunate with atovaquone-proguanil, AL artemether-lumefantrine, AS artesunate monotherapy, ASAQ artesunate-amodiaquine, ASMQ artesunate-mefloquine, ASSP artesunate-sulfadoxine-pyrimethamine, BMI body mass index, DP dihydroartemisinin-piperaquine, EGA estimated gestational age, HIV human immunodeficiency virus, Q quinine monotherapy, QC quinine with clindamycin, SD standard deviation